FrontView REIT, Inc.
FrontView REIT, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N A D G N N N Property Fund L P | - | - | - | - | - | - | - | 0 | |||||
Cash | - | - | - | - | - | - | - | 0 | |||||
Assets | |||||||||||||
Land | 351 | 337 | 329 | 326 | 330 | 341 | 333 | - | |||||
Real Estate Investment Pr… | |||||||||||||
Real Estate Investment Property At Cost | 809 | 768 | 747 | 725 | 732 | 754 | 719 | - | |||||
Buildings And Improvements Gross | 459 | 431 | 417 | 399 | 402 | 413 | 386 | - | |||||
Real Estate Investment Property Accumulated Deprec… | -54 | -51 | -48 | -45 | -44 | -44 | -40 | - | |||||
Real Estate Investment Property Net | 755 | 717 | 699 | 680 | 688 | 711 | 679 | - | |||||
Assets Of Disposal Group Including Discontinued Op… | 8 | 14 | 12 | 18 | 29 | 14 | 6 | - | |||||
Mortgage Loans On Real Estate Commercial And Consu… | 10 | 10 | 10 | 10 | 7 | - | - | - | |||||
Cash And Cash Equivalents At Carrying Value | 6 | 9 | 14 | 20 | 8 | 3 | 5 | - | |||||
Finite Lived Intangible Assets Net | 100 | 97 | 99 | 102 | 107 | 116 | 115 | - | |||||
Other Assets | 21 | 22 | 20 | 18 | 17 | 17 | 17 | - | |||||
Assets | 900 | 870 | 854 | 847 | 857 | 861 | 822 | 0 | |||||
Liabilities And Stockhold… | |||||||||||||
Long Term Debt | 329 | 313 | 314 | 307 | 317 | 310 | 267 | - | |||||
Liabilities | |||||||||||||
Below Market Lease Net | 14 | 14 | 14 | 14 | 15 | 16 | 15 | - | |||||
Liabilities | 372 | 356 | 361 | 343 | 353 | 345 | 299 | - | |||||
Accounts Payable And Accrued Liabilities Current A… | 29 | 29 | 32 | 22 | 21 | 19 | 18 | - | |||||
Equity | |||||||||||||
Preferred Stock Value | 0 | 0 | - | - | - | - | - | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||
Additional Paid In Capital Common Stock | 472 | 450 | 420 | 405 | 389 | 336 | 331 | 0 | |||||
Stockholders Equity | 529 | 418 | 391 | 504 | 370 | 516 | 325 | 181 | |||||
Retained Earnings Accumulated Deficit | -37 | -33 | -28 | -19 | -19 | -11 | -7 | - | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 2 | 1 | -1 | -1 | -1 | -0 | - | - | |||||
Minority Interest | 91 | 96 | 102 | 119 | 134 | 191 | 198 | - | |||||
Liabilities And Stockholders Equity | 900 | 870 | 854 | 847 | 857 | 861 | 822 | - | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 450 | 450 | 450 | 450 | 450 | 450 | 450 | 400 | |||||
Common Stock Shares Issued | 24 | 22 | 22 | 21 | 20 | 18 | 17 | 0 | |||||
Shares Outstanding | 24 | 22 | 22 | 21 | 20 | 18 | 17 | 0 | |||||
Preferred Stock Liquidation Preference Value | 25 | 25 | - | - | - | - | - | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.85% | 10.08% | 17.18% | - | - | - | - | - | - | - | - | - |
| 2025 | 0.78% | 9.96% | -0.44% | 4.93% | 10.59% | 5.74% | 11.63% | 9.13% | 20.27% | -6.03% | 6.55% | 7.23% |
| 2024 | - | - | - | - | - | - | 1.05% | -4.95% | -8.40% | -15.25% | -11.20% | -12.70% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
FrontView REIT, Inc. (FVR) — SEC Financial Statements & Analysis
FrontView REIT, Inc. (FVR) is a real estate investment trusts company, incorporated in MD. FrontView REIT, Inc. trades on NYSE as: FVR. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), FrontView REIT, Inc. reported a 41.93% year-over-year revenue growth, a Gross Profit Margin of 75.15% (TTM), a Price-to-Sales (P/S) ratio of 6.64x (TTM), a Price-to-Book (P/B) ratio of 0.87x (TTM), at a market cap of $461.88M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 41.93%
- Gross Profit Margin TTM
- 75.15%
- P/S TTM
- 6.64x
- P/B TTM
- 0.87x
- Market Cap
- $461.88M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is FrontView REIT, Inc. in?
FrontView REIT, Inc. (FVR) operates in the Real Estate Investment Trusts industry.
What is FVR's market cap?
FrontView REIT, Inc. (FVR) has a market capitalization of $461.88M as of 2026-06-30.
What is FVR's P/E ratio?
FrontView REIT, Inc. (FVR)'s trailing twelve month P/E ratio is 149.67x as of 2026-06-30.
What exchange does FVR trade on?
FrontView REIT, Inc. (FVR) trades on the NYSE.
Where is FrontView REIT, Inc. incorporated?
FrontView REIT, Inc. is incorporated in MD.